Home LiteratureArticle Details
PMID: 20036195 Published · ppublish English Comment Letter

IGF-1R targeted treatment of sarcoma.

The Lancet. Oncology ·Vol. 11 ·No. 2 ·2010-02-00 ·Pages 105-6

Toretsky JA, Gorlick R

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/therapeutic use Antineoplastic Agents/therapeutic use Cell Line, Tumor Humans Immunoglobulins, Intravenous Receptor, IGF Type 1/antagonists & inhibitors Sarcoma/drug therapy Sarcoma, Ewing/drug therapy
Chemicals
Antibodies, Monoclonal Antineoplastic Agents Immunoglobulins, Intravenous Receptor, IGF Type 1 figitumumab
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Toretsky Jeffrey A
Gorlick Richard
Article Info
Journal
The Lancet. Oncology
Abbr.
Lancet Oncol
ISSN
1474-5488
DOI
10.1016/S1470-2045(09)70391-2
Published
2010-02-00
Epub
2009-00-23
Pages
105-6
Language
English
Region
England
NLM ID
100957246
Subset
IM
Corrections
CommentOn
PMID: 20036194
External Links
PubMed source DOI: 10.1016/S1470-2045(09)70391-2 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2